According to reports, there are more than 8500 small and medium manufacturers with less than Rs 250 crore turnover in the ...
14 天
ThePrint on MSNIndian pharmas improved USFDA compliance, but cases of contamination grew 2014-2024—IPA ...The report, released at Global Pharmaceutical Quality Summit in Mumbai, draws comparison of incidences of ‘official action indicated' after USFDA inspections a decade apart.
In this context, Eminence Business Media will be holding the 5th Annual Pharma GMP and Quality Management 2025, from April 24 – 25, 2025, in Mumbai. The conference is co-located with Pharma Quality ...
Acquisition of the EU GMP certification facilitates Orchid Pharma to service its products to the global key markets and create a healthy international portfolio in perpetuity. The company is ...
Symbiosis Pharmaceutical Services has completed the latest inspection by the U.S. FDA of its facilities in Scotland.
Piramal Pharma’s facility in Turbhe ... A Form-483 with six observations was issued by the U.S. FDA after the General GMP inspection of the facility from February 11-17. The observations ...
WuXi Biologics (WuXi Bio), a leading global contract research, development, and manufacturing organization, announced that it has again passed the GMP inspection by Japan’s Pharmaceuticals and Medical ...
Lonza will leverage its expertise in exosome development and analytical services to define a GMP-compliant process for Exo-101 production.
The Indian pharma sector has grown at 8 per cent CAGR and has also seen a 9 per cent increase in export rates in 2024, according to a report.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果